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ABSTRACT.
Purpose: To assess the diagnostic accuracy and agreement between a paediatric
electroretinography protocol used at Great Ormond Street Hospital (GOSH-ERG)
and the ‘gold standard’ international protocol (ISCEV-ERG) in health and disease.
Methods: Patient databases between 2010 and 2020 were screened to identify
children with an ISCEV-ERG recorded within four years of a GOSH-ERG.
Electroretinogram(ERG)componentpeaktimesandamplitudeswerere-measured,
anddatawere analysed in termsof absolute abnormality and proportional deviation
from respective reference ranges. Abnormality was defined by the retinal system
affected and by individual ERG a- and b-wave component analysis.
Results: A total of 59 patients were included: 38 patients had retinal disease
defined by an abnormal ISCEV-ERG and 21 had normal ISCEV-ERGs. When
absolute abnormality was defined by combined retinal systems, the GOSH-ERG
showed an excellent overall sensitivity of 95% (accuracy 86%). Individual retinal
systems showed good–excellent sensitivity (67%–100%) and specificity (68%–
97%). Electroretinogram (ERG) component sensitivities ranged between 60%and
97% and specificities between 79% and 97% dependent upon the protocol step.
The proportional relationship appeared mostly linear between protocols. Elec-
troretinogram (ERG)morphology was comparable for both protocols in a range of
retinal diseases including those with pathognomonic ERGs.
Conclusion: We demonstrate the high diagnostic accuracy of a paediatric ERG
protocol (GOSH-ERG) relative to ISCEV standard ERGs. The close propor-
tional deviation and similar waveform morphology indicate ERGs from each
protocol are similarly affected in disease. This encourages the use of the GOSH-
ERG protocol in the screening, diagnosis and monitoring of retinal disease in
children who are unable to comply with the rigorous ISCEV-ERG protocol.
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Introduction
The full-field flash electroretinogram
(ERG) is a widely used diagnostic test
of generalized retinal function. The
flash ERG can identify a functional
abnormality within the retina. It is
typically recorded to protocols
described by the International Society
for Clinical Electrophysiology of
Vision (ISCEV) ERG standard
(McCulloch et al., 2015), which facili-
tates international communication and
comparison. This standard specifies the
stimulus and recording parameters for
six recording protocols, which bias or
preferentially elicit responses from dif-
ferent retinal systems to identify the
locus and extent of retinal dysfunction.
The ISCEV-ERG standard is regularly
updated and is an important step to
standardize work across international
laboratories (Hamilton, et al., 2015).
Whilst the ISCEV-ERG standard
can be applied successfully in young
children, by swaddling babies or dark
adapting in a different room whilst
taking consent under red light, it is a
lengthy test (Fulton, Hartmann &
Hansen, 1989; Tremblay & Parkinson,
2003; Bradshaw, Hansen & Fulton,
2004; van Genderen et al., 2006). The
ISCEV-ERG standard acknowledges it
is not easy to apply in ‘non-compliant
children between 2 and 5yrs’ and
abbreviated protocols may be neces-
sary (Fulton, Hartmann & Hansen,
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1989; Parness-Yossifon & Mets, 2008).
Some centres suggest the tests are
delayed until children are old enough
to comply and refer to the ‘toddler dip’
when ERGs are not performed (van
Genderen et al., 2006). The ISCEV-
ERG standard protocol requires a
period of dark adaptation (DA) and
light adaptation (LA) lasting 20 and
10 min, respectively, alongside pupil
dilation, a fixed position looking into
a Ganzfeld bowl for flash stimulation,
and ideally corneal electrodes. Skin
electrodes are now included as a less
invasive option in the most recent
standard update (McCulloch, et al.,
2015). The ISCEV-ERG standard is
preferred, but due to the long test time
some authors have explored shortening
the DA period to 10 min. This has
been shown to have little effect on the
mixed rod cone DA3 ERG and reduces
the amplitude of the rod-driven
DA0.01 ERG b-wave by 10%–13%
(Hamilton & Graham, 2016; Bach,
Meroni & Heinrich, 2020). Likewise,
the LA period has been reduced to
5 min with little effect on the LA3
response (Asakawa et al., 2019),
though differences in peripheral and
central retina LA timing have been
reported (Kondo et al 1999). To date,
these alterations to the ISCEV-ERG
protocol have been in healthy partici-
pants only and have not been verified
in patients with retinal disease. Alter-
natively, some centres therefore choose
to perform paediatric ERGs under
anaesthesia, circumstances that can
influence the ERG b-wave (Andreas-
son et al., 1993; Tremblay & Parkin-
son, 2003; Ioham et al., 2004;
Messenger, Yang, & Pennesi, 2014)
alongside having potential immediate
(cardiorespiratory) and uncertain long-
term effects on neurocognitive devel-
opment (O’Leary & Warner, 2017).
Others seek to introduce individual
elements of the ISCEV-ERG standard
gradually as compliance allows (Holder
& Robson, et. al., 2006). Others, such
as our centre, who do not have seda-
tion or anaesthesia resources available,
choose to use abbreviated and modified
paediatric ERG protocols until an alert
child is able to comply with the stan-
dard ISCEV-ERG test in full.
Tony Kriss first published a modi-
fied paediatric ERG protocol (GOSH-
ERG) in 1992, and it has been adopted
in a number of centres, including Great
Ormond Street Hospital for Children
for the investigation of paediatric reti-
nal disease (Kriss & Russell-Eggitt,
1992; Kriss et al., 1992; Kriss, 1994).
We have updated the protocol in line
with changes in the ISCEV-ERG stan-
dard, including the addition of a
stronger flash. The GOSH-ERG pro-
tocol has been developed to produce
similar responses to an ISCEV-ERG in
a 10 min test time. In brief, it adapts
the test delivery so that it is acceptable
to an alert child without sedation or
anaesthesia by using skin electrodes
with minimal dark adaption (<5 min),
and natural pupils to allow pattern
visual evoked potential (pVEP) testing
in the same appointment. The propor-
tional contributions of specific rod and
cone retinal systems are biased by
modifying background lighting, stimu-
lus flash strength and chromaticity.
The use of red and blue flashes has
been used widely in paediatric practice
by other units (Fulton, Hartman, &
Hansen, 1989; Brecelj & Stirn-Kranjc,
2004). The flash stimulus is produced
by a handheld stroboscope or LED
stimulator, which can be moved easily
to follow the head movements of a
child with natural pupils, although the
examiner should be aware of the inho-
mogeneity of the flash luminance
source and variable gaze direction,
which may influence retinal illumi-
nance and theoretically affect diagnos-
tic sensitivity.
Whilst the GOSH-ERG protocol
has been used over many years provid-
ing comparable diagnostic results in
clinical practice, its diagnostic accuracy
has not been validated against the ‘gold
standard’ of the ISCEV-ERG. This
validation is timely and necessary in
this genomic era, when treatments of
retinal disease and systemic disease
associated with retinal dysfunction are
translating rapidly into practice. Early
diagnosis is ever important. Increas-
ingly, ophthalmologists are being asked
to catalogue the retinal phenotype and
natural history of children in the non-
compliant age range (18 months-
5 years) in preparation for treatment
trials. The growing independence of
children in this age range alone makes
them less compliant and tolerant of an
ISCEV-ERG protocol, but if they also
have systemic disease associated with
neurodevelopmental delay or autistic
spectrum behaviours, their ability to
comply with the exactitude of position
and duration of an ISCEV-ERG is
severely reduced and a meaningful
alternative ERG method is needed.
Our study aimed to evaluate the
diagnostic agreement between GOSH-
ERG and ISCEV-ERG protocols and
to inform clinicians about the diagnos-
tic accuracy of this modified paediatric
ERG protocol.
Methods
A retrospective case note review was
conducted for all patients who had a
GOSH-ERG over a ten-year period
(2010–2020). These data were screened
to identify those patients who had a
‘gold standard’ ISCEV-ERG within
four years of the GOSH-ERG record-
ing date. The GOSH-ERG and
ISCEV-ERG waveforms were re-
measured by an experienced scientist
for peak time and amplitude of the a-
wave and b-wave components for each
eye. Data were considered abnormal if
they fell outside of the laboratory
reference ranges for each respective
ERG protocol. The analysis comprised
of two main considerations, one for
absolute abnormality (i.e. normal or
abnormal response) and also in relative
terms (i.e. proportional deviation away
from reference limit, such as amplitude
lower limit or peak time upper limit).
Electroretinograms (ERGs) from each
eye were considered together, with an
abnormal ERG result considered when
responses fell outside the reference
limits for both eyes. For measuring
proportional deviance from the refer-
ence value, each eye of each patient was
considered separately.
The GOSH-ERGs were recorded
according to our previously published
protocol (Kriss & Russell-Eggitt, 1992).
In brief, the patient has a visual evoked
potential recording in a darkened room
prior to ERG testing, and this begins
dark adaptation. Skin electrodes are
applied just below the lower lids, typi-
cally referred to an outer canthus elec-
trode. A handheld flash stimulator
(PS33 Photic Stimulator, Grass Instru-
ments) presents flashes at 3Hz, initially
with a moderate intensity (GR4 setting;
~5 cd.s.m2) 30cm away from the eyes to
produce a mixed rod-cone response
under scotopic conditions (room lit by
the TV only). The room lighting is then
darkened further, by turning off the TV,
and a dim blue flash (GR1 setting;
~0.1 cd.s.m2; Wratten filter 47
~440 nm) is presented at 50cm to
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produce a scotopic predominantly rod-
driven b-wave. [This step is typically
preceded by a scotopic red flash (GR4
setting; 0.1 cd.s.m2, Wratten filter 26
~619 nm) to assess scotopic cone func-
tion. This step was not included in this
study as it differs from the primary
ISCEV-ERG protocols.] The blue-
coloured filter is removed, and a single
bright flash (GR16 setting; ~21 cd.s.m2)
is delivered at 30cm in 10- to 20-second
intervals, to produce a scotopicmaximal
flash a-wave. The room lighting is then
turned on with additional bright light-
ing, and after 1–2 min, a photopic cone
ERG is produced to a moderate-
intensity flash (GR4 setting;
~5 cd.s.m2), followed by a 30Hz flicker
stimulus of the same intensity for the
photopic 30Hz response, each at 30cm
distance. Typically, averages of 30–100
responses aremade and repeated at least
twice to ensure repeatability and consis-
tency of waveform. Any abnormal or
spurious finding prompts additional
testing with increased and/or decreased
flash luminance. The entire ERG
recording session takes between 5 and
10 min in most children.
Results for ISCEV-ERG and
GOSH-ERG protocol steps were com-
pared as detailed in Table 1. Although
the GOSH-ERG examines eyes in a
slightly different physiological state of
light adaptation compared with the
ISCEV-ERG, each protocol step com-
pared in this study assesses broadly
similar retinal cell contributions. Typ-
ical waveforms produced by each step
are shown in Fig. 3.
To ascertain the different clinical
implications of our findings, results
were analysed in two ways: first by
retinal system and then by ERG com-
ponent. Details of this are provided in
Table 2. Abnormality of retinal system
was defined by grouping the diagnostic
ERGs, such as rod system determined
by the rod-driven inner retinal
response/DA 0.01 b-wave and rod
photoreceptors by the scotopic maxi-
mal flash/DA 10 a-wave. The ERG
component abnormalities (i.e. a- and b-
wave amplitudes and peak times of
ERG components) were considered
individually.
Abnormalities were sub-divided as
an ‘absolute’ abnormality, that is, nor-
mal or abnormal, or a relative abnor-
mality as an extent of deviation from
the reference limit. The analysis of
absolute abnormality used descriptive
and inferential statistics to assess agree-
ment and accuracy of the GOSH-ERG
relative to the ISCEV-ERG. The diag-
nostic accuracy, sensitivity, specificity,
positive predictive value (PPV) and
negative predictive value (NPV) were
calculated. Receiver operating charac-
teristic (ROC) curves were drawn, and
the area under the curve (AUC) was
used to measure the overall accuracy of
the GOSH-ERG protocol. Analysis for
the ‘relative’ abnormality was done by
plotting data points as a deviation from
their reference limit for each respective
protocol. These data were fitted with a
non-parametric locally weighted
regression (LOESS) to determine the
relationship of proportional deviation
of abnormality for each protocol. Fur-
thermore, example cases had their
ERG waveforms from each protocol
scaled and superimposed to observe
whether waveforms appeared qualita-
tively comparable between protocols.
This study received institutional
approvals (ref. 18BA43) and followed
the tenets of the most recent revision of
the Declaration of Helsinki.
Results
A total of 59 patients had both GOSH
and ISCEV-ERGs recorded within
4 years. Of this cohort, 38 patients
had abnormal ISCEV-ERGs (cone
dysfunction/dystrophy n = 10, cone-
rod dystrophy n = 2, rod-cone dystro-
phy n = 7, incomplete congenital sta-
tionary night blindness (iCSNB)
n = 12, complete CSNB (cCSNB)
n = 5, enhanced S-cone syndrome
n = 1 and KCVN2 retinopathy n = 1)
and the remaining 21 patients had
normal ISCEV-ERGs. The median
time in days between GOSH-ERG
and ISCEV-ERG was 47 days (range:
581 to 1378 days, IQR: 0–254 days).
The median age of this patient cohort
at the time of GOSH-ERG was
9.9 years (range: 5.6–22.8, IQR: 8.1–
12.9) and ISCEV-ERG was 10.3 years
(range: 6.0–22.8, IQR: 8.9–13.4). Based
upon our clinic patient audits, the
majority of patients seen with GOSH-
Table 1. Equivalent flash protocols between GOSH-ERG and ISCEV-ERG protocols for each




Scotopic predominantly rod-driven (dim blue flash
GR1)
DA 0.01 Rod-driven response
Scotopic mixed (moderate white flash GR4) DA 3 Scotopic mixed rod
cone
Scotopic maximal flash (bright white flash GR16) DA 10 Scotopic bright flash
Photopic cone (moderate white flash GR4) LA 3 Photopic cone
Photopic 30 Hz (moderate white 30 Hz GR4) LA 30 Hz Photopic 30 Hz
flicker
Table 2. Definitions of abnormality defined by system (top tier) and individual component
(bottom tier) in analysis.
Abnormality by system
Retinal system GOSH-abnormality ISCEV-ERG abnormality
Rod system Scotopic rod-driven b-wave DA 0.01 b-wave
Rod
photoreceptors
Scotopic maximal flash a-wave DA 10 a-wave
Cone system Photopic cone a- and b-waves and
photopic 30 Hz peak/amplitude
LA 3 a- and b-waves and LA
30Hz peak/amplitude
Inner-retina b:a amplitude ratio mixed rod cone b:a amplitude ratio DA 3
Abnormality by component
Rod-driven b-wave Scotopic rod-driven b-wave DA 0.01 b-wave
Scotopic mixed rod-cone Scotopic mixed rod-cone a- and b-waves DA 3 a- and b-waves
Scotopic maximal flash Scotopic max a- and b-waves DA 10 a- and b-waves
Photopic cone Photopic cone a- and b-waves LA 3 a- and b-waves
Photopic 30Hz flicker Photopic 30Hz waveform LA 3 waveform
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ERGs are <5 y/o, mostly 1–3 y/o,
though some patients continue to be
seen at our tertiary referral centre into
young adulthood due to rare and often
complex medical conditions.
Analysis of absolute abnormalities
Figure 1 shows the receiver operating
characteristic (ROC) curves for analy-
sis by system and by individual com-
ponent; qualitative terminology for
accuracy findings, such as excellent or
good, is consistent with those defined
by the International Federation of
Clinical Chemistry and Laboratory
Medicine (Simundic, 2009). The ROC
curve is a performance measurement of
a diagnostic test. It plots sensitivity (the
true-positive rate) on the y-axis against
1-specificity (false-positive rate) on the
x-axis. The closer the plot is to the top
left corner, the better the test perfor-
mance. The point of the plot nearest
the top left corner is the best compro-
mise between sensitivity and specificity,
in other words the most accurate point
for diagnosing an outcome – the
Youden index. If the plot falls on the
diagonal axis, where y = x (i.e. bottom
left to top right), this indicates a poor
performance as the test produces false-
positive result at the same rate as true-
positive result (Altman & Bland, 1994;
Schisterman et. al., 2005). The area
under the plotted curve (AUC) is a
global measure of a test ability to
discriminate if a condition is present
or not, in this circumstance the ability
to discriminate retinal dysfunction. An
AUC of 0.5 means discrimination is
not better than chance, whilst AUC of
1 is perfect discrimination.
Overall, the ROC curves of ERG
data demonstrated good–excellent clas-
sification of GOSH-ERG against the
ISCEV-ERG. In terms of system
abnormality, the GOSH-ERG protocol
showed high accuracy in all measures,
most notably in the detection of ‘rod
system’ or ‘cone system’ abnormalities
with sensitivities of 93% and 100%,
respectively. In terms of component
abnormalities, the rod-driven b-wave
showed high accuracy at 0.95 and
sensitivity at 93%, and other specific
measures showed good or high accu-
racy ranging between 0.7 and 0.9. The
sensitivity of these less accurate com-
ponents was high, with the cone-
mediated responses having 92% sensi-
tivity for the photopic cone ERG and
97% sensitivity for photopic 30Hz
flicker. The scotopic bright flash ERG
had the lowest sensitivity at 61%, but
high specificity at 88%, which is impor-
tant when considering the high sensi-
tivity of the rod-driven response as a
complementary rod system ERG mea-
sure. The AUC measurements showed
high global accuracy of the GOSH-
ERG protocol relative to the ISCEV-
ERG.
Table 3 data are presented with
abnormality defined in absolute terms.
The abnormality by system rows shows
very high or excellent diagnostic accu-
racy ranging between 0.86 and 0.95, and
slightly less but still high diagnostic
accuracy for abnormality by compo-
nent, ranging between 0.72 and 0.95.
Abnormality by system AUC data
shows all relationships have very good
or excellent accuracy (ranging between
0.80 and 0.95). Abnormality by compo-
nent demonstrates a wider range
between good and excellent global accu-
racy (0.74–0.95), with all measures
showing very good or excellent accu-
racy, with the exception of the scotopic
bright flash response, which showed
good accuracy. The discrepancy
between the accuracy of rod photore-
ceptor and scotopic bright flash
responses in system analysis and com-
ponent analysis, respectively, suggests
the scotopic bright flash response b-
wave is less comparable to the DA 10
ISCEV-ERG b-wave, as the a-wave (i.e.
that reflected in rod photoreceptor sys-
tem) had very good accuracy. The abil-
ity of the scotopic mixed rod-cone ERG
Fig. 1. Receiver operating characteristic (ROC) curves for GOSH-ERG and ISCEV-ERG accuracy. The left figure illustrates the relative accuracy of
the GOSH-ERG against ISCEV-ERG when defining abnormality by retinal systems. Each system is defined by its respective colour with an
abnormality in ‘any system’, that is overall sensitivity, seen from the black line. The right figure illustrates the relative accuracy of the GOSH-ERG
against ISCEV-ERG when defining abnormality by individual components.
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to detect any retinal abnormality was
also separately analysed, as this single
ERG step may be suitable for screening
or for patients who are particularly
challenging to test. Analysis at the
ocular level demonstrated the mixed
rod-cone ERG to have excellent sensi-
tivity and specificity (94.7% and 92.9%,
respectively) in detecting any retinal
abnormality (i.e. abnormal peak time,
amplitude or b:a ratio), with excellent
PPV and NPV also (96% an 90.7%,
respectively). Those eyes producing an
abnormal GOSH-ERG scotopic mixed
rod-cone but normal ISCEV-ERG(3/42
eyes) had normal amplitudes, but peak
times were 1ms early or later than the
reference range. The mixed rod-cone
ERG b-wave peak time was overall
delayed in those patients with cone
dysfunction (mean  SEM; 43.4 ms 
1.2 ms), and atypically early in those
with rod-cone dysfunction (36.4 ms 
2.1 ms), in keeping with the dependence
of b-wave peak time on the propor-
tional balance of rod versus cone
contribution.
Analysis of relative abnormalities
The degree of abnormality or deviation
was plotted for each major component
(from a- and b-wave component anal-
ysis) and displayed in Fig. 2. The data
in Fig. 2 demonstrate a consistent,
mostly linear relationship of the pro-
portionate deviation from the reference
limits for corresponding GOSH-ERG
and ISCEV-ERG protocol steps. The
majority of peak time differences of the
rod system b-waves fell within normal
limits. Of the data points that fell
outside the linear trend, most evident
were the photopic cone b-wave ampli-
tudes, which tended to demonstrate a
higher degree of abnormality in the
ISCEV-ERG than in the GOSH-ERG.
Nevertheless, the photopic cone ampli-
tude plot has narrow 95% confidence
bands, which trend linearly and overall
suggest good proportional agreement.
These data demonstrate the high
accuracy of the GOSH protocol in
terms of ERG retinal systems, which
form the clinical diagnosis, alongside
the individual components measured.
However, importantly in clinical prac-
tice, subtle alterations of ERG wave-
form morphology can also contribute
to a diagnosis. Therefore, example
ERG waveforms produced by patients
from each of the main diagnostic cat-
egories found in this cohort are pro-
vided in Fig. 3. ISCEV-ERG and
GOSH-ERG waveforms are overlaid
for comparable protocol steps. This
demonstrates the similarity of ERG
waveform morphology in both tech-
niques for childhood retinal dysfunc-
tion, including two patients with
pathognomonic waveforms of
enhanced S-cone syndrome and
KCVN2 retinopathy. Responses were
scaled appropriately, with GOSH-
ERGs scaled to 10% of ISCEV-
ERGs, similar to published values of
around 12% (Esakowitz et al., 1993).
Discussion
This within-subjects study compared a
modified protocol for recording paedi-
atric electroretinograms (GOSH-ERG)
against the gold standard (ISCEV-
ERG) protocol and found the GOSH-
ERG showed very good or excellent
overall diagnostic agreement with
ISCEV-ERG both in terms of abnor-
mality of retinal systems and individual
components. Furthermore, we have
demonstrated there is a proportionate
degree of abnormality from each pro-
tocol, with comparable waveform mor-
phology from the GOSH-ERG to
ISCEV-ERGs.
The GOSH-ERG protocol has been
used successfully since its inception to
evaluate retinal function in infants and
children and to provide long-term
monitoring and phenotyping of disease
(Jacobs, et al., 1992; Kriss & Russell-
Eggitt, 1992; Kriss, 1994; Lavy, et al.,
1995; Thompson, et al., 2013).
Although some studies have used both
the GOSH-ERG and ISCEV-ERG
protocols in children (Kurent et al.,
2015), there has not been to date an
empirical comparison with internation-
ally accepted ISCEV-ERG standards,
to demonstrate the relative diagnostic
accuracy of these measures.
The GOSH-ERG protocol demon-
strated excellent overall accuracy rela-
tive to ISCEV-ERGs in terms of
abnormality by retinal system analysis.
The ‘systems analysis’ approach is
typically used in clinical practice. It
considers corroborating information
from each step in the protocol to
identify an abnormality of retinal sys-
tems and classify a retinal dysfunction,
rather than depending upon a single
isolated abnormality. As such, GOSH-
ERGs identify abnormality in any
retinal system with excellent sensitivity
and with excellent and perfect
Table 3. This table contains the descriptive and inferential statistics determined from observing the sensitivity of the GOSH-ERG against the ISCEV-
ERG when defined by abnormality of retinal system (top table) and by individual component (bottom table).
Abnormality by System Accuracy of GOSH protocol 95% CI for accuracy Sensitivity Specificity PPV NPV AUC
Rod system 0.95 (0.8562, 0.9892) 0.93 0.97 0.96 0.93 0.95
Rod photoreceptors 0.86 (0.7462, 0.9385) 0.67 0.93 0.77 0.80 0.80
Cone system 0.91 (0.8102, 0.9714) 1.00 0.79 0.87 1.00 0.90
Inner retinal dysfunction 0.87 (0.7552, 0.9473) 0.74 0.94 0.88 0.87 0.84
Abnormality in any system 0.86 (0.7462, 0.9385) 0.95 0.68 0.86 0.87 0.82
Abnormality by Component Accuracy of GOSH protocol 95% CI for accuracy Sensitivity Specificity PPV NPV AUC
Rod-driven response 0.95 (0.8562, 0.9892) 0.93 0.97 0.96 0.93 0.95
Scotopic bright flash 0.72 (0.591, 0.8334) 0.61 0.88 0.87 0.63 0.74
Scotopic mixed rod cone 0.74 (0.6096, 0.8474) 0.71 0.90 0.97 0.39 0.80
Photopic cone 0.88 (0.767, 0.9501) 0.92 0.79 0.90 0.83 0.86
Photopic 30Hz flicker 0.90 (0.7883, 0.9611) 0.97 0.79 0.87 0.95 0.88
The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) are reported for each protocol component. The AUC
values reflect the area under the curve within the respective ROC curves produced. Diagnostic accuracy is provided in the far left column.
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sensitivities in rod and cone systems
(95%, 93% and 100%, respectively).
This is particularly important for early
diagnosis of retinal dysfunction, as the
GOSH-ERG is a preferred first inves-
tigation in ‘non-compliant’ patients
who are too young (i.e. within the
‘toddler dip’) or otherwise unable to
tolerate the exactitude of a standard
ISCEV-ERG recording, meaning a
high sensitivity is required for the early
detection of disease. In addition, we
found excellent specificity of the rod
photoreceptor systems from a-wave
measurements of 93%, complementing
the high rod system sensitivity. These
findings were supported by the ROC
curves, which demonstrated good–ex-
cellent area under curve (AUC) find-
ings in all abnormality classifications,
either by system or by component. We
also found very good and excellent
agreement, albeit less than in ‘systems’
analysis, for individual component
analysis. In particular, the measure-
ments of rod-driven responses and
cone-mediated responses had excellent
sensitivities of 93% and 92%, respec-
tively. Whilst the scotopic bright flash
had sufficient sensitivity (61%), it had
very good specificity (88%), which
complements the excellent sensitivity
of the rod-driven response in
characterizing the site of retinal dys-
function in these patients.
We did find low negative predictive
values (NPVs) in the scotopic mixed
rod-cone and scotopic bright flash
component analysis, which is an inter-
esting finding. However, as is per-
formed in practice, data are not
interpreted in isolation and ERGs must
be interpreted as a constellation of
features, as employed in our ‘systems’
analysis approach. As such, when these
abnormalities are considered as a reti-
nal system, such as reflecting rod sys-
tem, rod photoreceptors or cone
system, we found very good, excellent
and perfect NPVs of 0.93, 0.80 and 1.0,
respectively. The scotopic mixed rod-
cone GOSH-ERG is produced from a
less dark-adapted retina than an
ISCEV-ERG DA3 response; therefore,
the proportion of cones contributing to
the GOSH-ERG mixed rod-cone
response is higher. The waveform
shape supports this as the b-wave peak
time is earlier and the b-wave shape is
more sharply defined, evident in Fig. 3.
Therefore, we suspect the low NPV in
the scotopic mixed rod-cone response
reflects the different balance of rod-
cone contributions, which for the
GOSH-ERG is biased towards being
more cone mediated due to reduced
DA and higher stimulation rates (3Hz)
relative to the ISCEV-ERG DA 3
response. Furthermore, the flash stim-
ulator not being a uniform entire field
(i.e. Ganzfeld bowl) may contribute to
this discrepancy, perhaps reflecting dif-
ferent spatial inhomogeneities of rod
and cone photoreceptor contributions
to the recorded responses, though
averaging and the variation of flash
direction relative to the child will
dampen this somewhat. Nevertheless,
rod system ERGs [from scotopic rod-
driven and maximal flash responses]
were highly comparable and able to
delineate rod system dysfunction with
minimal DA. In addition, the indepen-
dent ability of the scotopic mixed rod-
cone ERG in detecting any retinal
abnormality showed an excellent sensi-
tivity and specificity (94.7% and
92.9%, respectively), suggesting this
response has clinical use as the first
protocol step of choice. The mixed rod-
cone ERG low false positives were due
to subtle peak time deviations of 1ms,
which clinically may be attributed to
ocular pigmentation (Abdleseaed et al.,
2010). Furthermore, it was reassuring
to observe that in two cases with
pathognomonic ERG features
(KCVN2 retinopathy and enhanced S-
cone syndrome), the distinctive
Fig. 2. Plots comparing proportionate differences between ISCEV-ERG and GOSH-ERG data fitted in using non-parametric locally weighted
regression (LOESS). The system components are labelled along the top of the figures. Data are plotted for their relative deviation from the respective
reference limits used within the study, normalized by percentage for the ISCEV-ERG (y-axis) and GOSH-ERG (x-axis). Data were fitted with a
locally weighted regression (LOESS) line (blue) with 95% confidence bands (grey shading). The top row illustrates the amplitude differences between
each system component, and the bottom row illustrates the peak time differences between the two protocols. The black graph line is the zero–zero
intercept; therefore, those data points falling to the bottom left quadrant are within normal limits for both tests, those within the upper left quadrant
suggest larger deviation from the reference value in the ISCEV-ERG than GOSH-ERG, and conversely those in the bottom right quadrant suggest
larger deviation from the reference value in the GOSH-ERG than ISCEV-ERG. The data points demonstrate some scatter, however, the LOESS line
demonstrates good correlation between each protocol.
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waveform features were observed in
both GOSH-ERG and ISCEV-ERGs,
the GOSH-ERG potentially providing
a means for earlier diagnosis (Vincent
et al., 2013).
The GOSH-ERG protocol allows
paediatric or abbreviated ERG testing
in a test time reduced to less than
10 min. Whilst we present strong find-
ings to advocate its use, our experience
emphasizes several technical factors,
which must be considered by those
wishing to incorporate this protocol
into practice. Firstly, the choice of
electrode is important to optimize the
signal-to-noise ratio; pregelled
electrodes can be more easily applied
and have lower impedance than cup-
based electrodes (Man, et al., 2020).
Secondly, the potential confounding
effect of eye position is particularly
relevant for infants. As the ERG signal
is maximal over the corneal apex
through the pupil aperture, upward
Fig. 3. Illustrative case examples from study patients with ISCEV-ERGs (black lines) and GOSH-ERGs (red lines). The study protocols are labelled
along the top of the illustrative panels. Protocols are dictated by those previously defined: rod-driven response (DA0.01 and scotopic rod-driven),
scotopic bright flash (DA10 and scotopic maximal flash), scotopic mixed rod-cone (DA3 and scotopic mixed rod-cone), photopic cone (LA3 and
photopic cone) and photopic 30 Hz flicker (LA30 Hz and photopic 30 Hz flicker). Time is displayed along the x-axis of each panel, with ISCEV-ERG
amplitude labelled along the left x-axis, and GOSH-ERG amplitude along the right x-axis, scaled to 10:1 µV, respectively, with traces overlaid.
Example cases are seen down the ensuing rows: A: A normal patient shows very similar waveform morphology for each comparable protocol. B: A
patient with cone dysfunction demonstrates similar rod-driven and scotopic bright flash ERGs, with very comparable cone-mediated ERG
waveforms. C: A patient with rod-cone dystrophy with no detectable ERGs to either protocol. D: A patient with iCSNB demonstrates relative
preservation of the rod-driven response and bright flash a-wave, alongside the degraded photopic cone and 30Hz ERGs for each protocol. E: A
patient with cCSNB demonstrates the absence of the rod-driven ERG and normal scotopic bright flash a-wave, with loss of oscillatory potentials. The
characteristic morphology of photopic cone ERG broadened a-wave trough and pointed b-wave peak, seen in ON-bipolar cell dysfunction, is evident
in both protocols. F: A patient with enhanced S-cone syndrome shows pathognomonic waveform features for each protocol; similarity of the scotopic
mixed rod-cone and photopic cone ERGs alongside the photopic cone a-wave being larger than 30Hz flicker amplitude. G: A patient with KCVN2
retinopathy shows the distinctly broadened scotopic bright flash a-wave morphology alongside degraded cone-mediated ERGs in each protocol.
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deviation of the eyes can reduce the
ERG amplitude recorded from a lower
lid electrode. It is therefore important
to note eye position, if possible encour-
age downward gaze towards the flash
stimulus, or interpret data incorporat-
ing any aberrant eye movements
(Kriss, 1994). Furthermore, one must
consider variance with ocular pigmen-
tation and retinal illumination from no
pupil dilation. Those with small pupils,
darkly pigmented irides and/or fundi
may have lower b-wave amplitudes,
whilst those with large pupils, lightly or
hypopigmented fundi may have a
larger amplitude, or sometimes smaller
amplitude photopic ERGs associated
with the photopic hill phenomenon
(Hamilton et al., 2007). Therefore,
any photopic b-wave abnormalities
should be investigated further by pre-
senting photopic flashes of higher or
lower stimulus strength to study the
dynamic changes in the b-wave.
The median age of our cohort was
around ten years. At this age, we expect
a neurodevelopmentally typical child to
reasonably tolerate the demands of an
ISCEV-ERG, though some of our
ISCEV-ERG cohort were as young as
five years. The youngest patient to have
successfully completed an ISCEV-ERG
within our laboratory was 3 years old,
although within this study the youngest
patient included was around five to
6 years old. In our practice, more than
50% of patients presenting for visual
electrophysiology tests are under
5 years, indeed the majority around
1–2 years of age falling within the
‘toddler dip’. In common with other
centres specializing in paediatric med-
icine, many children have not only
ocular but also systemic, neurological
or metabolic conditions, which means
test compliance is an important con-
sideration. For this reason, we use the
GOSH-ERG as a routine first test
across the paediatric age range. It is
less demanding than an ISCEV-ERG,
and these data show it allows highly
accurate and comparable diagnostic
outcomes within a 10-min test period,
without the need for anaesthetic, pupil
dilation or corneal electrodes. It is
encouraging, and perhaps implied from
our findings, that shorter periods of
DA or LA appear to only minimally
change the observed ISCEV-ERG in
healthy retina, reported in some studies
that have also used skin electrodes and
no mydriasis (Hamilton & Graham,
2016; Asakawa et al., 2019; Bach,
Meroni & Heinrich, 2020). This is an
exciting prospect for future ERG
recording methods, though these find-
ings await exploration in disease
groups to ensure their validity. Early
diagnosis and monitoring of retinal
function are particularly relevant in
this genomic era. The ERG may be
used to identify likely therapeutic win-
dows or as a functional outcome mea-
sure for gene therapy in inherited
retinal and systemic disease. Our find-
ings suggest that the overall sensitivity,
specificity and close proportional rela-
tionship between the GOSH-ERG and
ISCEV-ERG make the GOSH-ERG a
practical outcome measurement in
those patients who would otherwise
not be able to tolerate ERG testing.
Whilst we have not presented longitu-
dinal data within this cohort, the pro-
portional similarities between the
ISCEV-ERG and GOSH-ERG infer
that the GOSH-ERG is a valuable tool
in the longitudinal monitoring of
patients with retinal disease, and
indeed, this is used clinically. It should
be emphasized, however, that the
GOSH-ERG and ISCEV-ERG are
not directly comparable as the stimulus
and recording properties differ.
The GOSH-ERG utilizes a now
obsolete xenon flash stroboscope
(PS33 Photic Stimulator, Grass Instru-
ments) due to its ability to deliver
bright flashes within a very brief time
period. Whilst there were little further
technological developments to com-
pare to these original devices, a newer
commercially available light-emitting
diode (LED) flash stimulator is now
available, which has been shown to
provide comparable photometric and
ERG responses using the GOSH-ERG
protocol (Liasis et al., 2020). Lastly,
corneal electrodes are a disadvantage
for children. More pertinently within
the current SARS-CoV-2 international
pandemic, the need for infection pre-
vention and control is crucial. It has
been shown that SARS-CoV-2 is
detectable within the tear film in 24%
of patients with COVID-19 (Arora,
et al., 2020). Therefore, disposable
electrodes, such as the skin electrodes
used for the GOSH-ERG protocol,
minimize the risk of patient–patient
cross-infection or laboratory contami-
nation, alongside having much shorter
application and test times, which min-
imizes close patient–clinician
interactions. It has been shown more
recently that the GOSH-ERG protocol
can also be recorded using a handheld
ERG system (RETeval, LKC Tech-
nologies, Gaithersburg, USA) with
comparable findings to the conven-
tional GOSH-ERG in paediatric prac-
tice, which may offer an alternative,
useful point-of-care screening for reti-
nal disease (Carter et al., 2020).
Conclusion
We present data that validate a mod-
ified paediatric ERG protocol, the
GOSH-ERG, compared with the inter-
national standard ISCEV-ERG, in a
clinical cohort of patients with and
without retinal disease. These data
advocate the GOSH-ERG protocol as
a diagnostically accurate alternative for
screening or when ISCEV-ERG testing
is not practical in ‘non-compliant’
children. The benefits of the GOSH-
ERG protocol include a reduced test
time and lack of corneal electrodes,
pupil dilation or formal DA. All of
these advantages improve the test com-
pliance and quality of ERG data
recorded from less cooperative
children.
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